Localization of urokinase to focal adhesions by human fibrosarcoma cells synthesizing recombinant vitronectin
- 1 December 1996
- journal article
- Published by Canadian Science Publishing in Biochemistry and Cell Biology
- Vol. 74 (6) , 899-910
- https://doi.org/10.1139/o96-095
Abstract
Cell surface plasminogen activators have been proposed to participate in cell migration and invasion by activating both intracellular signaling pathways and extracellular proteolysis. Urokinase-type plasminogen activator (uPA) is secreted from many cell types and localizes to focal contact areas when cells are seeded onto the plasma protein vitronectin. Induction of vitronectin synthesis during migration of neural crest cells and growth of certain tumors suggests that the de novo synthesis and deposition of vitronectin into the tissue matrix may remodel the matrix to provide an environment suitable for cell migration and (or) tumor invasion. To investigate the effects of vitronectin secretion and matrix deposition on the localization and activity of cell-associated uPA, HT-1080 fibrosarcoma cells were transfected with the Rc/CMV expression vector containing a vitronectin cDNA insert and stable cell lines expressing vitronectin were selected. Vitronectin-secreting cells were allowed to attach and spread on collagen- and fibronectin-coated substrates. Within 6 h, vitronectin was detected on the substrate; vitronectin synthesis was accompanied by the clustering of both the αvβ5vitronectin receptor and uPA into vinculin-containing focal adhesions. Although mock transfected cells formed small focal adhesions on both collagen and fibronectin, no co-localization of uPA or αvβ5to focal adhesions was evident in these cells. Vitronectin-secreting cells also exhibited decreased levels of plasminogen activation and increased levels of cell adhesion as compared with the mock transfected cells. These data demonstrate that the synthesis of vitronectin and its matrix association by transfected HT-1080 fibrosarcoma cells results in localization of uPA to oαvβ5containing focal adhesions, decreased cell surface uPA activity, and an increase in cell adhesion.Key words: urokinase, vitronectin, focal adhesions, αvβ5integrin.Keywords
This publication has 34 references indexed in Scilit:
- Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and α2-macroglobulin receptor in human breast carcinomasInternational Journal of Cancer, 1996
- Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor-1 is associated with breast cancer progression: An immunohistochemical comparison of normal, benign, and malignant breast tissuesCancer, 1996
- Plasmin Abrogates αvβ5-Mediated Adhesion of a Human Keratinocyte Cell Line (HaCaT) to VitronectinExperimental Cell Research, 1995
- Distribution and lateral mobility of the urokinase-receptor complex at the cell surface.Journal of Histochemistry & Cytochemistry, 1993
- Plasminogen activator inhibitor type I stabilizes vitronectin-dependent adhesions in HT-1080 cells.The Journal of cell biology, 1990
- Serum-derived vitronectin influences the pericellular distribution of type 1 plasminogen activator inhibitor.The Journal of cell biology, 1990
- Conformational lability of vitronectin: induction of an antigenic change by alpha-thrombin-serpin complexes and by proteolytically modified thrombinBiochemistry, 1989
- Linkage of extracellular plasminogen activator to the fibroblast cytoskeleton: colocalization of cell surface urokinase with vinculin.The Journal of cell biology, 1988
- Glucocorticoid-modulated gene expression of tissue- and urinary-type plasminogen activator and plasminogen activator inhibitor 1 and 2.The Journal of cell biology, 1988
- Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cellsThe Journal of cell biology, 1987